XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 119,332 $ 150,279
Marketable securities available-for-sale 644,660 592,023
Accounts receivables, net of allowance for doubtful accounts of $12,313 at September 30, 2024 and December 31, 2023, respectively 73,334 40,607
Other receivables 1,943 3,926
Inventories 62,402 53,290
Prepaid expenses and other current assets 24,570 18,995
Total current assets 926,241 859,120
Property and equipment, net 37,420 37,297
Operating lease right-of-use assets 21,780 24,287
Goodwill 2,091 2,067
Other assets 74,458 74,325
Total assets 1,061,990 997,096
Current liabilities:    
Accounts payable 7,089 5,245
Accrued research and development 4,402 2,982
Accrued liabilities 54,102 49,448
Other current liabilities 4,437 4,520
Total current liabilities 70,030 62,195
Convertible Notes, net of debt discount of $1,939 and $2,802 at September 30, 2024 and December 31, 2023, respectively (Note 7) 223,561 222,698
Long-term portion of lease liabilities 26,607 29,720
CEPI accrual long-term (Note 6) 60,337 60,337
Other long-term liabilities 28 74
Total liabilities 380,563 375,024
Commitments and contingencies (Note 5)
Stockholders’ equity:    
Preferred stock: $0.001 par value, 5,000 shares authorized at September 30, 2024 and December 31, 2023; zero shares outstanding at September 30, 2024 and December 31, 2023 0 0
Common stock: $0.001 par value, 278,000 shares authorized at September 30, 2024 and December 31, 2023; 131,345 shares and 129,530 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively 131 130
Additional paid-in capital 1,591,107 1,554,634
Accumulated other comprehensive income (loss) 514 (2,108)
Accumulated deficit (910,325) (930,584)
Total stockholders’ equity 681,427 622,072
Total liabilities and stockholders’ equity $ 1,061,990 $ 997,096